Devil facial tumour disease (DFTD)

Devil facial tumour disease (DFTD) is an aggressive parasitic cancer found among Tasmanian devils, which are wild carnivorous mammals native to Australia and Tasmania. It is one of only two contagious cancers discovered by scientists.

109057176-111425.jpg109057176-111424.jpg

First discovered in 1996, the disease has led to a rapid decline in the Tasmanian devil population across the world. The most common signs of DFTD are lesions and lumps around the mouth, which then develop into cancerous tumors that spread to the rest of the animal's body. Death normally occurs within six months of contracting the disease. Preservation efforts involving breeding in captivity were implemented to save the population.

Overview

After devil facial tumour disease (DFTD) invades the devil's body, it creates huge facial tumors that prevent the animal from eating or drinking. It then spreads to other organs. The animals normally die within six months of infection, either as a direct result of the cancer or due to starvation/dehydration. By 2024, the disease had wiped out about 80 percent of the world's Tasmanian devils.

Spread and Treatment

Scientists at first believed the cancer was caused by a viral infection. The true origin of DFTD was discovered in 2009 by a group of Australian scientists, who published their findings in the journal Science. The group reported that the devils transmit the disease when they bite each other's faces during fights. This makes the cancer highly contagious. DFTD is invisible to the devils' immune systems because it does not have the specific kind of surface molecules that would allow the devil's body to detect the foreign cells. Researchers noticed that the cancer cell's detection molecule is not the result of a permanent genetic mutation, however. The molecule still exists within the cancer cell's DNA, leading scientists to believe that the cell's invisibility could be reversed through genetic engineering.

Experiments proved the scientist's hypothesis correct. By introducing a molecule that encourages the production of cancer-fighting proteins in the devils' DNA, they were able to reverse the cancer cell's invisibility. The animal's immune system recognizes the cells as foreign and begins attacking them.

Scientists from the Menzies Institute for Medical Research planned a trial for a vaccine against the disease in late 2024, giving the vaccine to twenty-two devils held captive. They planned to include the vaccine in the food fed to the animals. The scientists expected a few trials of the vaccine.

Bibliography

Augustine, Judy. "Fight to Save Our Devils from Extinction Hinges on New Vaccine." Kids News, 15 May 2024, www.kidsnews.com.au/animals/fight-to-save-our-devils-from-extinction-hinges-on-new-vaccine/news-story/869abfe8487dc93d7f51039d8b593602. Accessed 14 Nov. 2024.

Jones, Menna E., et al. "Life-History Change in Disease-Ravaged Tasmanian Devil Populations." Proceedings of the National Academy of Sciences. National Academy of Sciences. 105.29 (2008): 10023-10027. Print. Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481324/

Pappas, Stephanie. "How Contagious Tasmanian Devil Cancer Goes Invisible." LiveScience. Purch. 11 March 2013. Web. 21 Nov. 2015. http://www.livescience.com/27804-contagious-devil-tumor-disease.html

Rehmeyer, Julie. "Fatal Cancer Threatens Tasmanian Devil Populations." Discover. Kalmbach Publishing Co. 31 Mar. 2014. Web. 21 Nov. 2015. http://discovermagazine.com/2014/may/13-the-immortal-devil

Yong, Ed. "Vaccine Hope for Tasmanian Devil Tumour Disease." Nature. Nature Publishing Group. 11 Mar. 2013. Web. 21 Nov. 2015. http://www.nature.com/news/vaccine-hope-for-tasmanian-devil-tumour-disease-1.12576

Zimmer, Carl. "Scientists Discover Origin of a Cancer in Tasmanian Devils." New York Times. New York Times Company. 31 Dec. 2009. Web. 21 Nov. 2015. http://www.nytimes.com/2010/01/01/science/01devil.html?‗r=0